Skip to main content
. 2007 Mar 30;2(3):e13. doi: 10.1371/journal.pctr.0020013

Figure 2. Antiviral Efficacy of ABC.

Figure 2

The percentage of participants in the two arms of the trial (ABC arm is the further bar to the right at each time point) on the y-axis with undetectable plasma HIV viral load at the beginning, week 4, and at the end of the trial (week 12).